Society announces inaugural fellows class for Academy of Immuno-Oncology
Click Here to Manage Email Alerts
The Society for Immunotherapy of Cancer announced the inaugural class of Fellows of the Academy of Immuno-Oncology.
The society established the academy to honor individuals who helped cancer immunotherapy become a breakthrough cancer treatment.
The inaugural fellows class will be honored at the society’s annual meeting, scheduled for Nov. 10-14 in Washington, D.C. SITC plans to induct a new class of fellows each year, with the next round of nominations scheduled for spring of 2022.
This year’s fellows are James P. Allison, PhD, of The University of Texas MD Anderson Cancer Center; Lieping Chen, MD, PhD, of Yale School of Medicine; Zelig Eshhar, PhD, of Weizmann Institute of Science and the Tel Aviv Sourasky Medical Center; Gordon J. Freeman, PhD, of Dana-Farber Cancer Institute; Philip D. Greenberg, MD, of Fred Hutchinson Cancer Research Center; Tasuku Honjo, MD, PhD, of Kyoto University Graduate School of Medicine; Elizabeth M. Jaffee, MD, of Sidney Kimmel Cancer Center at Johns Hopkins University; Carl H. June, MD, of University of Pennsylvania; Alan J. Korman, PhD, of Vir Biotechnology; Margaret L. Kripke, PhD, of The University of Texas MD Anderson Cancer Center; Ronald Levy, MD, of Stanford University; Steven A. Rosenberg, MD, PhD, of NCI/NIH; Robert D. Schreiber, PhD, of Washington University School of Medicine; Arlene H. Sharpe, MD, PhD, of Harvard Medical School; and Thomas A. Waldmann, MD, of NCI/NIH (posthumous).
Click Here to Manage Email Alerts